Non-invasive Diagnostic and Prognostic Assay for Early Stage Lung Cancer
Bioportfolio,
09:49 EST 29 Nov 2017 | NIH There are now more than 155,000 deaths per year in the US, and over 8 million high-risk individuals.
Noninvasive Urinary Metabolomic Profiling Identifies Diagnostic and Prognostic Markers in Lung Cancer
Overview of attention for article published in Cancer Research, June 2014
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (92nd percentile)
-
High Attention Score compared to outputs of the same age and source (87th percentile)
Readers on
- mendeley
- 169 Mendeley